FDA warns of rare risk of long-lasting erections in males taking Methylphenidate ADHD medications


The FDA ( Food and Drug Administration ) has warned that Methylphenidate products, one type of stimulant drug used to treat attention deficit hyperactivity disorder ( ADHD ), may in rare instances cause prolonged and sometimes painful erections known as priapism.
FDA continues to monitor the safety of drugs after they are approved, and, based on a recent review of Methylphenidate products. The drug labels and patient Medication Guides have been updated to include information about the rare but serious risk of priapism.

Patients who take Methylphenidate and develop erections lasting longer than four hours should seek immediate medical treatment to prevent long-term problems with the penis. If not treated right away, priapism can lead to permanent damage to the penis.

Priapism can occur in males of any age and happens when blood in the penis becomes trapped, leading to an abnormally long-lasting and sometimes painful erection. Younger males, especially those who have not yet reached puberty, may not recognize the problem or may be embarrassed to tell anyone if it occurs.
All male patients and their caregivers should be taught the signs and symptoms of priapism and the importance of seeking immediate medical treatment if it occurs.

Methylphenidate products are among the medicines that can be used to treat ADHD. One of the most common childhood brain disorders, ADHD can continue through adolescence and adulthood and causes symptoms such as difficulty staying focused and paying attention, difficulty controlling behavior, and hyperactivity.
Medications such as Methylphenidate used to treat ADHD benefit patients with the disorder by increasing focus, reducing impulsivity, and improving overall social functioning.
Therefore, patients who have been prescribed a Methylphenidate product should not stop taking it without first talking to their health care professionals.

Methylphenidate products marketed in the United States include: Concerta, Daytrana, Focalin / Focalin XR, Metadate CD / Metadate ER, Methylin / Methylin ER, Quillivant XR, Ritalin / Ritalin LA / Ritalin SR.

In FDA review, the median age of patients taking a Methylphenidate product who experienced priapism was 12.5 years ( range 8 to 33 years ). In a few patients, priapism occurred after an increase in the dosage of Methylphenidate, but priapism has also occurred under other conditions, such as during short periods of time when the drug was stopped temporarily, when there was a longer than typical time between doses, or after stopping the drug permanently.
Two patients required surgical intervention; one required shunt placement, and the other had to have needle aspiration of the corpus cavernosum.

The risk of priapism may cause some health care professionals toconsider switching patients to the non-stimulant drug Strattera ( Atomoxetine ), another drug used to treat ADHD; however, Atomoxetine has also been associated with priapism in young children, teenagers, and adults.
Priapism appears to be more common in patients taking Atomoxetine than in patients taking Methylphenidate products. Health care professionals should be cautious when considering changing patients from Methylphenidate to Atomoxetine.

Amphetamine products are also used to treat ADHD, and FDA has received reports of priapism in four patients taking an Amphetamine product. However, whether the Amphetamine products caused the priapism is uncertain, because all of these patients had been taking other medications that are thought to cause priapism. Therefore, FDA cannot conclude that the use of Amphetamine products can result in priapism. ( Xagena )

Source: FDA, 2013

XagenaMedicine_2013



Indietro

Altri articoli

Given the rapidly increasing use of stimulant medications during pregnancy and among women of reproductive age who may become pregnant...


Adults with attention-deficit / hyperactivity disorder ( ADHD ) show a blunted response to the Methylphenidate ( Ritalin ), which...


A study has assessed the effectiveness of Phenylephrine, the active ingredient in products such as Actifed, Sudafed PE, and...


The FDA ( Food and Drug Administration ) directed the manufacturers of all drug products approved for the treatment of...


Cocaine use during pregnancy can cause subtle but disabling cognitive impairments -- attention deficits, learning disabilities and emotional problems. A...


A fifth of young adults whose blood vessels ruptured inside their brain abused drugs and more than 40 percent had...


Researchers at University of Toronto have discovered a new mechanism for the neurodegenerative effects of amphetamines. These drugs are converted...


A study led by Pastor R. Couceyro, at Rosalind Franklin University of Medicine and Science and colleagues at Amgen sheds...


A research published in the American Journal of Psychiatry indicates that methamphetamine abuse and HIV infection cause significant alterations in...